Demographics and concomitant disorders in heart failure

被引:123
作者
Krum, H
Gilbert, RE
机构
[1] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Prevent Med, Melbourne, Vic 3181, Australia
[2] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Med, Melbourne, Vic 3181, Australia
[3] Monash Univ, Alfred Hosp, Sch Med,NHMRC Ctr Clin Res Excellence Therape, Dept Epidemiol, Melbourne, Vic 3181, Australia
[4] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia
关键词
D O I
10.1016/S0140-6736(03)13869-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic heart failure is an increasingly common cause of premature death and poor quality of life. Community-based epidemiological studies have provided much-needed information on the demography of chronic heart failure, providing insight into its influence on public health. In most patients, chronic heart failure Is accompanied by a range of concomitant disorders that both contribute to the cause of the disease and have a key role in its progression and response to treatment. Information on the most common comorbidities in chronic heart failure-ischaemic heart disease, hypertension, and diabetes mellitus-is presented for prespecifled subgroups in the reports of many large-scale, multicentre trials; despite their limitations, these subanalyses provide guidance in therapeutic decision-making. Similarly, because chronic heart failure is commonly an endpoint in intervention trials of both hypertension and diabetes, such studies afford important information on the prevention of chronic heart failure in these common diseases.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 162 条
[31]   Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction [J].
Dries, DL ;
Sweitzer, NK ;
Drazner, MH ;
Stevenson, LW ;
Gersh, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :421-428
[32]  
Eichhorn E, 2001, NEW ENGL J MED, V344, P1659
[33]   CLINICAL OUTCOME OF PATIENTS WITH ADVANCED CORONARY-ARTERY DISEASE AFTER VIABILITY STUDIES WITH POSITRON EMISSION TOMOGRAPHY [J].
EITZMAN, D ;
ALAOUAR, Z ;
KANTER, HL ;
VOMDAHL, J ;
KIRSH, M ;
DEEB, GM ;
SCHWAIGER, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (03) :559-565
[34]   CORONARY-ARTERY BYPASS-GRAFTING IN SEVERE LEFT-VENTRICULAR DYSFUNCTION - EXCELLENT SURVIVAL WITH IMPROVED EJECTION FRACTION AND FUNCTIONAL-STATE [J].
ELEFTERIADES, JA ;
TOLIS, G ;
LEVI, E ;
MILLS, LK ;
ZARET, BL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) :1411-1417
[35]   Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. [J].
Exner, DV ;
Dries, DL ;
Domanski, MJ ;
Cohn, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1351-1357
[36]   Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure [J].
Feenstra, J ;
Grobbee, DE ;
Mosterd, A ;
Stricker, BHC .
DRUG SAFETY, 1997, 17 (03) :166-180
[37]  
Floras JS, 1998, EUR HEART J, V19, P820
[38]  
Ghali J K, 1997, J La State Med Soc, V149, P474
[39]   Chronic heart failure in the United States - A manifestation of coronary artery disease [J].
Gheorghiade, M ;
Bonow, RO .
CIRCULATION, 1998, 97 (03) :282-289
[40]   EPIDEMIOLOGY OF HEART-FAILURE IN THE UNITED-STATES [J].
GILLUM, RF .
AMERICAN HEART JOURNAL, 1993, 126 (04) :1042-1047